Skip to main content

Cabergoline Tablets

Last Updated: December 8, 2022
Status: Current

Products Affected - Description
    • Cabergoline tablet, Par Pharmaceuticals, 0.5 mg, bottle, 8 count, NDC 49884-0673-14 - discontinued
    • Cabergoline tablet, Teva, 0.5 mg, bottle, 8 count, NDC 00093-5420-88
Reason for the Shortage
    • Ingenus has cabergoline tablets available.
    • Par discontinued cabergoline.
    • Teva did not provide a reason for the shortage.
    • Viatris has cabergoline tablets available.
Available Products
    • Cabergoline tablet, Greenstone (Viatris), 0.5 mg, bottle, 8 count, NDC 59762-1005-01
    • Cabergoline tablet, Ingenus Pharmaceuticals, 0.5 mg, bottle, 8 count, NDC 50762-0118-08

Estimated Resupply Dates

    • Teva has cabergoline 0.5 mg tablets on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated December 8, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 2, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.